1.56
price up icon0.94%   0.01
 
loading
Precedente Chiudi:
$1.55
Aprire:
$1.58
Volume 24 ore:
47,823
Relative Volume:
0.12
Capitalizzazione di mercato:
$58.69M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+8.28%
1M Prestazione:
+5.72%
6M Prestazione:
-25.85%
1 anno Prestazione:
-76.11%
Intervallo 1D:
Value
$1.55
$1.59
Intervallo di 1 settimana:
Value
$1.40
$1.6494
Portata 52W:
Value
$1.23
$8.1747

Metagenomi Inc Stock (MGX) Company Profile

Name
Nome
Metagenomi Inc
Name
Telefono
(510) 871-4880
Name
Indirizzo
5959 HORTON STREET, EMERYVILLE
Name
Dipendente
202
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MGX's Discussions on Twitter

Confronta MGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MGX
Metagenomi Inc
1.56 58.69M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
430.77 128.45B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 65.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
546.21 40.09B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.75 35.67B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
223.00 27.44B 3.81B -644.79M -669.77M -6.24

Metagenomi Inc Stock (MGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-07 Iniziato H.C. Wainwright Buy
2024-05-02 Downgrade JP Morgan Overweight → Neutral
2024-03-05 Iniziato BMO Capital Markets Outperform
2024-03-05 Iniziato Chardan Capital Markets Buy
2024-03-05 Iniziato JP Morgan Overweight
2024-03-05 Iniziato Jefferies Buy
2024-03-05 Iniziato TD Cowen Outperform
2024-03-05 Iniziato Wells Fargo Overweight
Mostra tutto

Metagenomi Inc Borsa (MGX) Ultime notizie

pulisher
May 12, 2025

Metagenomi (MGX) and Its Competitors Head-To-Head Review - Defense World

May 12, 2025
pulisher
May 11, 2025

Metagenomi (MGX) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Metagenomi, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsMGX - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Metagenomi, Inc. (MGX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

May 09, 2025
pulisher
May 06, 2025

Wells Fargo & Company MN Increases Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 06, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Has $555,000 Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 04, 2025
pulisher
May 04, 2025

JPMorgan Chase & Co. Acquires 65,020 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 04, 2025
pulisher
May 02, 2025

Metagenomi Inc [MGX] stock for 1,744 USD was sold by Wein Matthew - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

Metagenomi Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Market Update: Metagenomi Inc (MGX) Sees Negative Movement, Closing at 1.49 - DWinneX

May 02, 2025
pulisher
May 02, 2025

Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 01, 2025

Metagenomi Inc (NASDAQ: MGX)’s -10.37-Percent Loss Of This Past Week Taught Us Something New - Marketing Sentinel

May 01, 2025
pulisher
May 01, 2025

Geode Capital Management LLC Has $2.12 Million Stock Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 01, 2025
pulisher
Apr 29, 2025

Metagenomi, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MGX - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 25, 2025

Levi & Korsinsky Notifies Shareholders of Metagenomi, Inc.(MGX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Metagenomi (MGX) versus Its Competitors Critical Analysis - Defense World

Apr 24, 2025
pulisher
Apr 18, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Apr 18, 2025
pulisher
Apr 16, 2025

Corebridge Financial Inc. Grows Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Apr 16, 2025
pulisher
Apr 14, 2025

Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Metagenomi, Inc. - marketscreener.com

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Acquires New Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Prudential Financial Inc. - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 08, 2025

Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st

Apr 08, 2025
pulisher
Apr 08, 2025

Can you still get a good price for Metagenomi Inc (MGX) Shares at this point? - uspostnews.com

Apr 08, 2025
pulisher
Apr 08, 2025

Levi & Korsinsky Reminds Shareholders of an Investigation into Metagenomi, Inc. (MGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 08, 2025

Metagenomi Inc Azioni (MGX) Dati Finanziari

Non sono disponibili dati finanziari per Metagenomi Inc (MGX). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Metagenomi Inc Azioni (MGX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Wapnick Pamela
Chief Financial Officer
Mar 05 '25
Sale
1.87
1,808
3,390
59,684
Wapnick Pamela
Chief Financial Officer
Dec 05 '24
Sale
1.86
1,559
2,900
61,492
Wapnick Pamela
Chief Financial Officer
Sep 05 '24
Sale
2.88
6,265
18,043
63,051
$66.94
price up icon 4.19%
$19.14
price up icon 0.83%
$32.84
price down icon 0.27%
$24.37
price up icon 5.66%
$96.10
price down icon 0.57%
biotechnology ONC
$224.65
price up icon 0.54%
Capitalizzazione:     |  Volume (24 ore):